Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors.
Gu H, Yan W, Wang Y, Xu W, Huang L, Yang J, Zhai B, Wang H, Su Y, Zhu Q, Liu B, Hao H, Zou Y, Xu Y.
Gu H, et al. Among authors: xu w, xu y.
J Med Chem. 2023 Jan 12;66(1):473-490. doi: 10.1021/acs.jmedchem.2c01452. Epub 2022 Dec 28.
J Med Chem. 2023.
PMID: 36576395